Pharmacological and Non-Pharmacological Management of Obstructive Sleep Apnea
Life Sciences- Dentistry
DOI:
https://doi.org/10.22376/ijlpr.2023.13.6.L531-L542Keywords:
obstructive sleep apnea (OSA), mandible advancements, oral appliances, pharmacotherapy.Abstract
Obstructive sleep apnea (O.S.A.), also referred to as obstructive sleep hypopnea – is a sleep disorder that involvescessation or significant decrease in airflow in the presence of breathing effort. It is the most common type of sleep-disorderedbreathing. It is characterized by episodes of total or partial airway collapse and decreased oxygen saturation or sleep arousal. Asa result of this disturbance, sleep is interrupted and non-restorative. It significantly raises morbidity and mortality in both developedand developing countries. This review aims to review relevant studies on obstructive sleep apnea. The method used is acomputerized search method, the pathophysiology, clinical presentation, complications, diagnostic procedures, and therapeuticchoices from the literature. The effects of O.S.A. on cardiovascular health, mental disease, quality of life, and driving safety aresevere. This course of action highlights the interprofessional team's involvement in treating obstructive sleep apnea, itspathophysiology, and its causes.
References
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine task force. Sleep. 1999 Aug 1;22(5):667-89. doi: 10.1093/sleep/22.5.667, PMID 10450601.
Park JG, Ramar K, Olson EJ. Updates on definition, consequences, and management of obstructive sleep apnea. Mayo Clin Proc. 2011 Jun;86(6):549-54; quiz 554. doi: 10.4065/mcp.2010.0810, PMID 21628617.
Arredondo E, Udeani G, Panahi L, Taweesedt PT, Surani S. Obstructive sleep apnea in adults: what primary care physicians need to know. Cureus. 2021 Sep;13(9):e17843. doi: 10.7759/cureus.17843, PMID 34660049.
Budhiraja R, Parthasarathy S, Quan SF. Endothelial dysfunction in obstructive sleep apnea. J Clin Sleep Med. 2007 Jun 15;3(4):409-15. doi: 10.5664/jcsm.26864, PMID 17694731.
Nokes B, Raza H, Malhotra A. Pulmonary hypertension and obstructive sleep apnea. J Clin Sleep Med. 2020 Apr 15;16(4):649. doi: 10.5664/jcsm.8302, PMID 32022678.
Tietjens JR, Claman D, Kezirian EJ, De Marco T, Mirzayan A, Sadroonri B, et al. Obstructive sleep apnea in cardiovascular disease: a review of the literature and proposed multidisciplinary clinical management strategy. J Am Heart Assoc. 2019 Jan 8;8(1):e010440. doi: 10.1161/JAHA.118.010440, PMID 30590966.
Porto F, Sakamoto YS, Salles C. Association between obstructive sleep apnea and myocardial infarction: A systematic review. Arquivos Brasileiros de Cardiologia [internet]; 2017 [cited Apr 23 2023]. Available from: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2017000400361.
Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019 Aug;7(8):687-98. doi: 10.1016/S2213-2600(19)30198-5, PMID 31300334.
Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg. 2016 Dec;45(1):43. doi: 10.1186/s40463-016-0156-0, PMID 27542595.
Cistulli PA, Armitstead J, Pepin JL, Woehrle H, Nunez CM, Benjafield A, et al. Short-term CPAP adherence in obstructive sleep apnea: a big data analysis using real-world data. Sleep Med. 2019 Jul;59:114-6. doi: 10.1016/j.sleep.2019.01.004, PMID 30799254.
Floras JS. Obstructive sleep apnea syndrome, continuous positive airway pressure and treatment of hypertension. Eur J Pharmacol. 2015 Sep;763(A):28-37. doi: 10.1016/j.ejphar.2015.06.024, PMID 26096557.
Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomized prospective parallel trial. Lancet. 1999 Jun;353(9170):2100-5. doi: 10.1016/S0140-6736(98)10532-9, PMID 10382693.
Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA, Bailey D, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006 Mar;29(3):375-80. doi: 10.1093/sleep/29.3.375, PMID 16553024.
Drager LF, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest. 2011 Aug;140(2):534-42. doi: 10.1378/chest.10-2223, PMID 21813534.
Leinum CJ, Dopp JM, Morgan BJ. Sleep-disordered breathing and obesity: pathophysiology, complications, and treatment. Nutr Clin Pract. 2009 Dec;24(6):675-87. doi: 10.1177/0884533609351532, PMID 19955545.
van Lunteren E, Strohl KP. The muscles of the upper airways. Clin Chest Med. 1986 Jun;7(2):171-88. doi: 10.1016/S0272-5231(21)00414-7, PMID 3522067.
Schwab RJ, Gupta KB, Gefter WB, Metzger LJ, Hoffman EA, Pack AI. Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls. Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1673-89. doi: 10.1164/ajrccm.152.5.7582313, PMID 7582313.
Haponik EF, Smith PL, Bohlman ME, Allen RP, Goldman SM, Bleecker ER. Computerized tomography in obstructive sleep apnea. Correlation of airway size with physiology during sleep and wakefulness. Am Rev Respir Dis. 1983 Feb;127(2):221-6. doi: 10.1164/arrd.1983.127.2.221, PMID 6830039.
Moser RJ, Rajagopal KR. Obstructive sleep apnea in adults with tonsillar hypertrophy. Arch Intern Med. 1987 Jul;147(7):1265-7. doi: 10.1001/archinte.1987.00370070079012, PMID 3606283.
Iida-Kondo C, Yoshino N, Kurabayashi T, Mataki S, Hasegawa M, Kurosaki N. Comparison of tongue volume/oral cavity volume ratio between obstructive sleep apnea syndrome patients and normal adults using magnetic resonance imaging. J Med Dent Sci. 2006 Jun;53(2):119-26. PMID 16913573.
Lyberg T, Krogstad O, Djupesland G. Cephalometric analysis in patients with obstructive sleep apnoea syndrome.: I. Skeletal morphology. J Laryngol Otol. 1989 Mar;103(3):287-92. doi: 10.1017/s0022215100108734, PMID 2703770.
Malhotra A, Huang Y, Fogel RB, Pillar G, Edwards JK, Kikinis R, et al. The male predisposition to pharyngeal collapse: importance of airway length. Am J Respir Crit Care Med. 2002 Nov 15;166(10):1388-95. doi: 10.1164/rccm.2112072, PMID 12421747.
Pae EK, Lowe AA, Fleetham JA. A role of pharyngeal length in obstructive sleep apnea patients. Am J Orthod Dentofacial Orthop. 1997 Jan;111(1):12-7. doi: 10.1016/s0889-5406(97)70296-8, PMID 9009918.
Berthon-Jones M, Sullivan CE. Ventilation and arousal responses to hypercapnia in normal sleeping humans. J Appl Physiol Respir Environ Exerc Physiol. 1984 Jul 1;57(1):59-67. doi: 10.1152/jappl.1984.57.1.59, PMID 6432751.
Shea SA, Edwards JK, White DP. Effect of wake‐sleep transitions and rapid eye movement sleep on pharyngeal muscle response to negative pressure in humans. J Physiol. 1999 Nov;520(3):897-908. doi: 10.1111/j.1469-7793.1999.00897.x, PMID 10545152.
Doi Y, Ueda K, Ogino K, Hayashi T, Takahashi A, Waki K, et al. Incidence of non‐benign arrhythmia in neonatal intensive care unit: 18 years experience from a single center. J Arrhythm. 2022 Jun;38(3):363-8. doi: 10.1002/joa3.12694, PMID 35785397.
Wiegand DA, Latz B, Zwillich CW, Wiegand L. Upper airway resistance and geniohyoid muscle activity in normal men during wakefulness and sleep. J Appl Physiol (1985). 1990 Oct 1;69(4):1252-61. doi: 10.1152/jappl.1990.69.4.1252, PMID 2262442.
Rowley JA, Zahn BR, Babcock MA, Badr MS. The effect of rapid eye movement (REM) sleep on upper airway mechanics in normal human subjects. J Physiol. 1998 Aug;510(3):963-76. doi: 10.1111/j.1469-7793.1998.00963.x, PMID 9660905.
Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest. 1992 May 1;89(5):1571-9. doi: 10.1172/JCI115751, PMID 1569196.
Mezzanotte WS, Tangel DJ, White DP. Influence of sleep onset on upper-airway muscle activity in apnea patients versus normal controls. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1880-7. doi: 10.1164/ajrccm.153.6.8665050, PMID 8665050.
Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991 Nov 1;14(6):540-5. doi: 10.1093/sleep/14.6.540, PMID 1798888.
Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the Multiple Sleep Latency Test (MSLT): A standard measure of sleepiness. Sleep. 1986 Dec;9(4):519-24. doi: 10.1093/sleep/9.4.519, PMID 3809866.
Sangal RB, Thomas L, Mitler MM. Maintenance of wakefulness test and multiple sleep latency test. Measurement of different abilities in patients with sleep disorders. Chest. 1992 Apr;101(4):898-902. doi: 10.1378/chest.101.4.898, PMID 1555459.
Netzer N, Eliasson AH, Netzer C, Kristo DA. Overnight pulse oximetry for sleep-disordered breathing in adults: a review. Chest. 2001 Aug;120(2):625-33. doi: 10.1378/chest.120.2.625, PMID 11502669.
Spicuzza L, Caruso D, Di Maria G. Obstructive sleep apnoea syndrome and its management. Ther Adv Chronic Dis. 2015 Sep;6(5):273-85. doi: 10.1177/2040622315590318, PMID 26336596.
Bloch KE. Alternatives to CPAP in the treatment of the obstructive sleep apnea syndrome. Swiss Med Wkly. 2006 May 6;136(17-18):261-7. doi: 10.4414/smw.2006.11158, PMID 16741848.
Strohl KP, Brown DB, Collop N, George C, Grunstein R, Han F, et al. An official American Thoracic Society clinical practice guideline: sleep apnea, sleepiness, and driving risk in noncommercial drivers. An update of a 1994 statement. Am J Respir Crit Care Med. 2013 Jun 1;187(11):1259-66. doi: 10.1164/rccm.201304-0726ST, PMID 23725615.
Epstein LJ, Kristo D, Strollo PJ, Friedman N, Malhotra A, Patil SP, et al. Clinical guidelines for the evaluation, management, and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009 Jun 15;5(3):263-76. doi: 10.5664/jcsm.27497, PMID 19960649.
Qaseem A, Holty JE, Owens DK, Dallas P, Starkey M, Shekelle P et al. Management of obstructive sleep apnea in adults: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013 Sep 24;159(7):471-83. doi: 10.7326/0003-4819-159-7-201310010-00704, PMID 24061345.
Randerath WJ, Verbraecken J, Andreas S, Bettega G, Boudewyns A, Hamans E, et al. Non-CPAP therapies in obstructive sleep apnoea. Eur Respir J. 2011 May 1;37(5):1000-28. doi: 10.1183/09031936.00099710, PMID 21406515.
Kuna ST, Reboussin DM, Strotmeyer ES, Millman RP, Zammit G, Walkup MP, et al. Effects of weight loss on obstructive sleep apnea severity. Ten-year results of the sleep AHEAD study. Am J Respir Crit Care Med. 2021 Jan 15;203(2):221-9. doi: 10.1164/rccm.201912-2511OC, PMID 32721163.
Resta O, Foschino-Barbaro MP, Legari G, Talamo S, Bonfitto P, Palumbo A, et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord. 2001 May;25(5):669-75. doi: 10.1038/sj.ijo.0801603, PMID 11360149.
Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000 Dec 20;284(23):3015-21. doi: 10.1001/jama.284.23.3015, PMID 11122588.
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993 Apr 29;328(17):1230-5. doi: 10.1056/NEJM199304293281704, PMID 8464434.
Wang SH, Keenan BT, Wiemken A, Zang Y, Staley B, Sarwer DB, et al. Effect of weight loss on upper airway anatomy and the apnea–hypopnea index. The importance of tongue fat. Am J Respir Crit Care Med. 2020 Mar 15;201(6):718-27. doi: 10.1164/rccm.201903-0692OC, PMID 31918559.
Winslow DH, Bowden CH, DiDonato KP, McCullough PA. A randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phentermine/topiramate for the treatment of obstructive sleep apnea in obese adults. Sleep. 2012 Nov;35(11):1529-39. doi: 10.5665/sleep.2204, PMID 23115402.
Blackman A, Foster GD, Zammit G, Rosenberg R, Aronne L, Wadden T, et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes (Lond). 2016 Aug;40(8):1310-9. doi: 10.1038/ijo.2016.52, PMID 27005405.
Sprung VS, Kemp GJ, Wilding JP, Adams V, Murphy K, Burgess M, et al. Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without continuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive sleep apnoEa (OSA) (ROMANCE): study protocol assessing the effects of weight loss on the apnea–hypnoea index (AHI). BMJ, (Open). 2020 Jul;10(7):e038856. doi: 10.1136/bmjopen-2020-038856, PMID 32699168.
Ogilvie RP, Patel SR. The epidemiology of sleep and diabetes. Curr Diab Rep. 2018 Oct;18(10):82. doi: 10.1007/s11892-018-1055-8, PMID 30120578.
Muraki I, Wada H, Tanigawa T. Sleep apnea and type 2 diabetes. J Diabetes Investig. 2018 Sep;9(5):991-7. doi: 10.1111/jdi.12823, PMID 29453905.
Rössner S, Sjöström L, Noack R, Meinders AE, Noseda G. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res. 2000 Jan;8(1):49-61. doi: 10.1038/oby.2000.8, PMID 10678259.
Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet. 1998 Jul;352(9123):167-72. doi: 10.1016/S0140-6736(97)11509-4.
Magliulo G, Iannella G, Ciofalo A, Polimeni A, De Vincentiis M, Pasquariello B, et al. Nasal pathologies in patients with obstructive sleep apnoea. Acta Otorhinolaryngol Ital. 2019 Aug;39(4):250-6. doi: 10.14639/0392-100X-2173, PMID 30933181.
An Y, Li Y, Kang D, Sharama-Adhikari SK, Xu W, Li Y, et al. The effects of nasal decongestion on obstructive sleep apnoea. Am J Otolaryngol. 2019;40(1):52-6. doi: 10.1016/j.amjoto.2018.08.003, PMID 30243839.
Kohler M, Bloch KE, Stradling JR. The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring. Eur Respir J. 2007 Aug 9;30(6):1208-15. doi: 10.1183/09031936.00032007, PMID 18055705.
Wijesuriya NS, Eckert DJ, Jordan AS, Schembri R, Lewis C, Meaklim H, et al. A randomised controlled trial of nasal decongestant to treat obstructive sleep apnoea in people with cervical spinal cord injury. Spinal Cord. 2019 Jul;57(7):579-85. doi: 10.1038/s41393-019-0256-6, PMID 30760846.
Berlowitz DJ, Brown DJ, Campbell DA, Pierce RJ. A longitudinal evaluation of sleep and breathing in the first year after cervical spinal cord injury. Arch Phys Med Rehabil. 2005 Jun;86(6):1193-9. doi: 10.1016/j.apmr.2004.11.033, PMID 15954059.
Marklund M, Franklin KA. Dental appliances in the treatment of snoring. A comparison between an activator, a soft-palate lifter, and a mouth-shield. Swed Dent J. 1996;20(5):183-8. PMID 9000327.
Ramar K, Dort LC, Katz SG, Lettieri CJ, Harrod CG, Thomas SM, et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med. 2015 Jul 15;11(7):773-827. doi: 10.5664/jcsm.4858, PMID 26094920.
Dieltjens M, Vanderveken O. Oral appliances in obstructive sleep apnea. Healthcare (Basel). 2019 Nov 8;7(4):141. doi: 10.3390/healthcare7040141, PMID 31717429.
Chan AS, Cistulli PA. Oral appliance treatment of obstructive sleep apnea: an update. Curr Opin Pulm Med. 2009 Nov;15(6):591-6. doi: 10.1097/MCP.0b013e3283319b12, PMID 19710614.
George PT. A modified functional appliance for treatment of obstructive sleep apnea. J Clin Orthod. 1987 Mar;21(3):171-5. PMID 3471767.
Liu Y, Zeng X, Fu M, Huang X, Lowe AA. Effects of a mandibular repositioner on obstructive sleep apnea. Am J Orthod Dentofacial Orthop. 2000 Sep;118(3):248-56. doi: 10.1067/mod.2000.104831, PMID 10982924.
Bonham PE, Currier GF, Orr WC, Othman J, Nanda RS. The effect of a modified functional appliance on obstructive sleep apnea. Am J Orthod Dentofacial Orthop. 1988 Nov;94(5):384-92. doi: 10.1016/0889-5406(88)90127-8, PMID 3189241.
Eveloff SE, Rosenberg CL, Carlisle CC, Millman RP. Efficacy of a Herbst mandibular advancement device in obstructive sleep apnea. Am J Respir Crit Care Med. 1994 Apr;149(4 Pt 1):905-9. doi: 10.1164/ajrccm.149.4.8143054, PMID 8143054.
Schmidt-Nowara WW, Meade TE, Hays MB. Treatment of snoring and obstructive sleep apnea with a dental orthosis. Chest. 1991 Jun;99(6):1378-85. doi: 10.1378/chest.99.6.1378, PMID 2036819.
Tsuiki S, Lowe AA, Almeida FR, Kawahata N, Fleetham JA. Effects of mandibular advancement on airway curvature and obstructive sleep apnoea severity. Eur Respir J. 2004 Feb;23(2):263-8. doi: 10.1183/09031936.04.00094304, PMID 14979501.
Ng A, Gotsopoulos H, Darendeliler AM, Cistulli PA. Oral appliance therapy for obstructive sleep apnea. Treat Respir Med. 2005;4(6):409-22. doi: 10.2165/00151829-200504060-00005, PMID 16336026.
Clark GT, Arand D, Chung E, Tong D. Effect of anterior mandibular positioning on obstructive sleep apnea. Am Rev Respir Dis. 1993 Mar;147(3):624-9. doi: 10.1164/ajrccm/147.3.624, PMID 8442597.
Pitsis AJ, Darendeliler MA, Gotsopoulos H, Petocz P, Cistulli PA. Effect of vertical dimension on efficacy of oral appliance therapy in obstructive sleep apnea. Am J Respir Crit Care Med. 2002 Sep 15;166(6):860-4. doi: 10.1164/rccm.200204-342OC, PMID 12231498.
Vanderveken OM, Devolder A, Marklund M, Boudewyns AN, Braem MJ, Okkerse W, et al. Comparison of a custom-made and a thermoplastic oral appliance for the treatment of mild sleep apnea. Am J Respir Crit Care Med. 2008 Jul 15;178(2):197-202. doi: 10.1164/rccm.200701-114OC, PMID 17673699.
Quinnell TG, Bennett M, Jordan J, Clutterbuck-James AL, Davies MG, Smith IE, et al. A crossover randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea (TOMADO). Thorax. 2014 Oct;69(10):938-45. doi: 10.1136/thoraxjnl-2014-205464, PMID 25035126.
Ramar K, Dort LC, Katz SG, Lettieri CJ, Harrod CG, Thomas SM, et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med. 2015 Jul 15;11(7):773-827. doi: 10.5664/jcsm.4858, PMID 26094920.
Wade PS. Oral appliance therapy for snoring and sleep apnea: preliminary report on 86 patients fitted with an anterior mandibular positioning device, the silencer. J Otolaryngol. 2003;32(2):110-3. doi: 10.2310/7070.2003.37144, PMID 12866596.
Lowe AA. Titratable oral appliances for the treatment of snoring and obstructive sleep apnea. J Can Dent Assoc. 1999 Nov;65(10):571-4. PMID 10612935.
Giannasi LC, Almeida FR, Magini M, Costa MS, De Oliveira CS, De Oliveira JCM, et al. Systematic assessment of the impact of oral appliance therapy on the temporomandibular joint during treatment of obstructive sleep apnea: long-term evaluation. Sleep Breath. 2009 Nov;13(4):375-81. doi: 10.1007/s11325-009-0257-3, PMID 19437057.
Kraiczi H, Hedner J, Dahlöf P, Ejnell H, Carlson J. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep. 1999 Feb 1;22(1):61-7. PMID 9989366.
Prasad B, Radulovacki M, Olopade C, Herdegen JJ, Logan T, Carley DW. Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome. Sleep. 2010 Jul;33(7):982-9. doi: 10.1093/sleep/33.7.982, PMID 20614859.
Carley DW, Olopade C, Ruigt GS, Radulovacki M. Efficacy of mirtazapine in obstructive sleep apnea syndrome. Sleep. 2007 Jan;30(1):35-41. doi: 10.1093/sleep/30.1.35, PMID 17310863.
Hedner J, Kraiczi H, Peker Y, Murphy P. Reduction of sleep-disordered breathing after physostigmine. Am J Respir Crit Care Med. 2003 Nov 15;168(10):1246-51. doi: 10.1164/rccm.200211-1344OC, PMID 12958052.
Moraes W, Poyares D, Sukys-Claudino L, Guilleminault C, Tufik S. Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study. Chest. 2008 Mar;133(3):677-83. doi: 10.1378/chest.07-1446, PMID 18198262.
Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax. 2004 Jan;59(1):50-5. PMID 14694248.
Clarenbach CF, Kohler M, Senn O, Thurnheer R, Bloch KE. Does nasal decongestion improve obstructive sleep apnea? J Sleep Res. 2008 Dec;17(4):444-9. doi: 10.1111/j.1365-2869.2008.00667.x, PMID 18710420.
Jokic R, Klimaszewski A, Mink J, Fitzpatrick MF. Surface tension forces in sleep apnea: the role of a soft tissue lubricant: A randomized double-blind, placebo-controlled trial. Am J Respir Crit Care Med. 1998 May 1;157(5 Pt 1):1522-5. doi: 10.1164/ajrccm.157.5.9708070, PMID 9603132.
Morrell MJ, Arabi Y, Zahn BR, Meyer KC, Skatrud JB, Badr MS. Effect of surfactant on pharyngeal mechanics in sleeping humans: implications for sleep apnoea. Eur Respir J. 2002 Aug;20(2):451-7. doi: 10.1183/09031936.02.00273702, PMID 12212981.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Jahnavi Purna Gorripati, Surekha Dubey Godbole
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
